The Central Drugs Standard Control Organization (CDSCO) has brought around 500 pharmaceutical plants under its lens for quality related issues. The first leg of an inspection drive to ascertain whether these manufacturing units are conforming to quality standards, is already under way.

The initiative, the biggest undertaken by the drug regulator so far, is aimed at curbing the proliferation of substandard drugs in the market.

Under the CDSCO’s new “risk-based” inspection system of manufacturing sites, it aims to “cleanse the system completely” according to a Health Ministry official.

Hygiene and qualifications of the personnel (at the plant) as well as internal testing procedures are among the parameters that will be reviewed, and Government will take action if there is a shortfall on any count. Major lapses could even lead to suspension of manufacturing licences.

CDSCO has currently sent out seven teams to check compliance issues in Andhra Pradesh, Telangana, Uttar Pradesh, Punjab, Gujarat and Assam. More teams will be deployed shortly.


Guide to approaching a consumer court

India's first practical guide to resolving your complaints by approaching consumer court. Guidance
Customer Complaint


Enter your email address to subscribe to our Newsletter.